ARCHIVES

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

This article is from The Cancer Letter archive.

Vol. 25 No. 41 | October 29, 1999

Download PDF Visit The Full Archive

Related Articles

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NIH RFA Available

August 3, 2001

In Brief: National Patient Advocates Foundation Formed To Seek Health Insurance Reform

November 15, 1996

Tempero, Johnson Take ASCO Offices

June 6, 2003

Cancer Death Rates Improving, But Still Higher, In Blacks

February 23, 2007

Bob Young To Head Centers & Community Oncology; Meyers Takes Medicine Branch

March 18, 1988